Simba Gill
Directeur/Membre du Conseil chez FOGHORN THERAPEUTICS INC.
Fortune : 199 481 $ au 30/04/2024
Postes actifs de Simba Gill
Sociétés | Poste | Début | Fin |
---|---|---|---|
FOGHORN THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/07/2017 | - |
Independent Dir/Board Member | 01/07/2017 | - |
Historique de carrière de Simba Gill
Anciens postes connus de Simba Gill
Sociétés | Poste | Début | Fin |
---|---|---|---|
EVELO BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/06/2015 | 20/11/2023 |
Directeur Général | 01/06/2015 | 20/11/2023 | |
Directeur Financier/CFO | 03/06/2022 | 01/09/2022 | |
President | 01/06/2015 | 20/11/2023 | |
Treasurer | 01/02/2020 | 01/06/2021 | |
REALM THERAPEUTICS PLC | Directeur/Membre du Conseil | 01/01/2016 | 01/01/2019 |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Directeur/Membre du Conseil | 01/01/2006 | 01/01/2015 |
Directeur Général | 01/01/2006 | 01/01/2015 | |
Fondateur | 01/01/2006 | 01/01/2015 | |
President | 01/01/2006 | 01/01/2015 | |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Directeur Financier/CFO | 01/01/1997 | 27/11/2013 |
President | 01/01/1997 | 27/11/2013 | |
TPG Growth LLC
TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | Private Equity Investor | - | 30/11/2007 |
Blackfynn, Inc.
Blackfynn, Inc. Internet Software/ServicesTechnology Services Blackfynn, Inc. provides treatments for neurological disease. Its new tools and technologies are generating. The company was founded by Amanda Christini and Joost Wagenaar and is headquartered in Philadelphia, PA. | Président | - | - |
CODEXIS, INC. | Directeur/Membre du Conseil | - | - |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Corporate Officer/Principal | - | - |
░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - | - |
Formation de Simba Gill
INSEAD | Masters Business Admin |
King's College London | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Royaume-Uni | 3 |
France | 2 |
Opérationnelle
Director/Board Member | 5 |
President | 3 |
Director of Finance/CFO | 2 |
Sectorielle
Health Technology | 5 |
Commercial Services | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
EVELO BIOSCIENCES, INC. | Health Technology |
CODEXIS, INC. | Process Industries |
FOGHORN THERAPEUTICS INC. | Health Technology |
Entreprise privées | 7 |
---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
TPG Growth LLC
TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | Finance |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Commercial Services |
Blackfynn, Inc.
Blackfynn, Inc. Internet Software/ServicesTechnology Services Blackfynn, Inc. provides treatments for neurological disease. Its new tools and technologies are generating. The company was founded by Amanda Christini and Joost Wagenaar and is headquartered in Philadelphia, PA. | Technology Services |
Realm Therapeutics Plc
Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA. | Health Technology |
- Bourse
- Insiders
- Simba Gill
- Expérience